Home › Stocks › Moderna

Moderna Inc. (MRNA)

Nasdaq Global Select

$218.01

▼ $18.49 (-7.82%)

Trade Moderna (MRNA) with a $100K Funded Account

Q: How do I qualify to trade Moderna Inc. (MRNA) and what is the profit split?

You can start trader2B® FREE $100K evaluation with no upfront cost or credit card required. After meeting the performance requirements and passing the evaluation, you can receive a live funded account with a 50% profit split. Traders who want higher payout percentages can choose paid Funded Trader Pricing – ToroChallenge® Plans | trader2B® offering up to 95%–99% profit splits. Symbol availability depends on the eligible symbol list for each program.

Q: Why are some U.S. stocks not available to trade on trader2B®?

trader2B® limits its eligible symbol list based on liquidity, price, short-sale availability, risk, and overall market quality. Stocks with low trading volume, very low prices, wide bid-ask spreads, limited short availability, or elevated manipulation risk may be excluded from the FREE $100K ToroChallenge®. You can view the current list of approved stocks on the eligible symbol list

Q: What platforms can I use to trade MRNA with trader2B®?

trader2B® WebTrader: A fast, browser-based platform requiring zero software downloads. trader2B® Desktop: A high-performance downloadable application for Windows, macOS, and Linux, equipped with multi-monitor support, Level II data, and hotkey execution. trader2B® Mobile App: Mobile trading available on both iOS (App Store) and Android (Google Play) to monitor and manage open positions on the go. API Trading: Automated execution and custom algorithmic trading enabled via the optional trader2B® API add-on

Q: How much buying power do I get to trade MRNA?

Traders starting the FREE $100K ToroChallenge® are allocated up to $100,000 in intraday buying power to trade eligible U.S. equities, including Moderna Inc. (MRNA). For traders seeking greater capital scaling, our advanced paid tiers provide up to $250,000 in total buying power with flexible account reset options. You can compare all available capital allocations and upgrade paths directly on our plans page.

Trade MRNA and top U.S. stocks through trader2B^® FREE $100K Challenge. Pass and receive a live funded account after approval, with 50% of your trading profits.

FREE funded path profit split: 50% after qualification.

✓ 100% FREE

- No credit card

✓ U.S. Stocks

- Real market data*

✓ Profit Split

- 50% on FREE $100K account

✓ Trading Style

- Day Trading

100% FREE

No credit card

U.S. Stocks

Real market data*

Profit Split

50% on FREE $100K account

Trading Style

Day Trading

Start FREE $100k Challenge

Open $235.00

Previous Close $236.50

Day High $237.96

Day Low $208.92

Volume $21.4M

Market Cap $87.04B

Moderna Financial Highlights

EPS -$7.26

Revenue $1.94B

Dividend $0.00

52 Week Low $22.28

52 Week High $176.66

200 MA $48.73

Latest Moderna (MRNA) Stock News

Recent company and market developments from original news sources.

Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus SeekingAlpha·Oct 18, 2026 Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. Motley Fool·Oct 18, 2026 The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going Motley Fool·Oct 17, 2026 Tough Trading Leaves Indices In The Red SeekingAlpha·Oct 17, 2026 Tech Weekly: Chip Stocks Sink on Hot Inflation Data, Debt Worries Investing News Network·Oct 16, 2026

Statement of changes in beneficial ownership of securities - Form 4 SEC Filings (All years)·Oct 16, 2026 Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39 SeekingAlpha·Oct 16, 2026 Nasdaq plunges 2% and these 15 names have led the downward decline SeekingAlpha·Oct 16, 2026 Moderna falls ahead of cancer vaccine data next week SeekingAlpha·Oct 16, 2026 Moderna Inc. (NASDAQ: MRNA) Draws the Stock Spotlight on Oct. 16 IBN Spotlights·Oct 16, 2026

About Moderna (MRNA) Stock

Intismeran autogene (intismeran; V940 or mRNA-4157) is a novel, potential first-in-class investigational messenger RNA (mRNA)-based individualized neoantigen therapy (INT) jointly developed by Merck and Moderna. Intismeran is designed and produced using a patient's tumor sample to identify the unique mutational signature, or 'fingerprint,' of their cancer and generate an anti-tumor immune response. Each therapy consists of a synthetic mRNA coding for up to 34 neoantigens and is tailored to the unique biology of an individual patient's tumor. Upon administration, the RNA-encoded neoantigen sequences are translated in the body and presented to the immune system, a key step in generating specific T-cell responses against cancer cells. Individualized neoantigen therapies are designed to train and activate an anti-tumor immune response based on the unique mutational signature of a patient's tumor.

Trade U.S. Stocks with trader2B

FREE $100K ToroChallenge®

Learn more →

FREE $100K trading rules

Learn more →

Eligible U.S. stocks & ETFs

Learn more →

trader2B trading platform

Learn more →

Compare ToroChallenge® funded plans

Learn more →

Moderna Inc. Stock Insights

View More Blog →

Uncategorized Quick-Hit Sessions bei 1Red Casino: Schnelle Runden, Klare Entscheidungen, Soforter Spaß

Einige Spieler bevorzugen es, sich auf lange Sicht einzurichten. Andere nicht. Wenn Sie der Typ...

Read article → Uncategorized Mostbet Azərbaycan – platformaya ümumi baxış

Mostbet Azərbaycan – platformaya ümumi baxış ▶️ OYNA Содержимое Qeydiyyat və hesabın yaradılması Bonus və...

Read article → Uncategorized Mostbet Azərbaycan – oyunlar və imkanlar

Mostbet Azərbaycan – oyunlar və imkanlar ▶️ OYNA Содержимое Qeydiyyat və hesab açma prosesi Depozit...

Read article →

Explore other popular U.S. stocks.

View all stocks →

Frequently Asked Questions About MRNA Trading

FREE $100K account, trading rules, payouts, hours and algo trading.

What should traders know before trading MRNA?

Moderna (MRNA) trading conditions on the NGS can vary significantly due to shifting daily volume and bid-ask spreads. Technical day traders often evaluate real-time order book liquidity and key chart levels, such as its 200-day moving average of $$48.73, before executing a trade.

What are the rules for day trading MRNA on a funded account?

Stocks must be included on the eligible symbol list to be traded in the FREE $100K ToroChallenge®. For approved U.S. equities, regular market hours are 9:30 AM to 4:00 PM New York time. Under the trading rules, all positions must be closed before the end of the trading session; overnight holding is not permitted.

How do I qualify to trade Moderna Inc. (MRNA) and what is the profit split?

You can start trader2B^® FREE $100K evaluation with no upfront cost or credit card required. After meeting the performance requirements and passing the evaluation, you can receive a live funded account with a 50% profit split. Traders who want higher payout percentages can choose paid Funded Trader Pricing – ToroChallenge® Plans | trader2B® offering up to 95%–99% profit splits. Symbol availability depends on the eligible symbol list for each program.

Can I use algorithms or API bots to trade MRNA?

Trading Moderna Inc. (MRNA) requires the stock to be on our active eligible symbol list. For all approved equities, standard execution on the FREE $100K ToroChallenge® is manual. If you want to deploy automated bots, algorithmic strategies, or custom scripts, you can unlock API trading as an optional premium feature. Manage your keys and enable API access directly through the Trader2B add-ons page.

Why are some U.S. stocks not available to trade on trader2B^®?

trader2B^® limits its eligible symbol list based on liquidity, price, short-sale availability, risk, and overall market quality. Stocks with low trading volume, very low prices, wide bid-ask spreads, limited short availability, or elevated manipulation risk may be excluded from the FREE $100K ToroChallenge^®. You can view the current list of approved stocks on the eligible symbol list

How and when can I withdraw profits after trading MRNA on a funded account?

After passing the evaluation and being approved for a live funded account, you can request payouts based on the profit split and withdrawal rules for your program. Payout eligibility depends on maintaining the required risk limits and following the funded account rules. For current payout terms and withdrawal requirements, please review the trading rules.

What platforms can I use to trade MRNA with trader2B^®?

trader2B^® WebTrader: A fast, browser-based platform requiring zero software downloads.
trader2B^® Desktop: A high-performance downloadable application for Windows, macOS, and Linux, equipped with multi-monitor support, Level II data, and hotkey execution.
trader2B^® Mobile App: Mobile trading available on both iOS (App Store) and Android (Google Play) to monitor and manage open positions on the go.
API Trading: Automated execution and custom algorithmic trading enabled via the optional trader2B^® API add-on

How much buying power do I get to trade MRNA?

Traders starting the FREE $100K ToroChallenge^® are allocated up to $100,000 in intraday buying power to trade eligible U.S. equities, including Moderna Inc. (MRNA). For traders seeking greater capital scaling, our advanced paid tiers provide up to $250,000 in total buying power with flexible account reset options. You can compare all available capital allocations and upgrade paths directly on our plans page.

Can I get a higher profit split than the FREE $100K Challenge?

Yes. Traders who want a higher potential profit split can choose a paid ToroChallenge® plan: Toro25 up to 95%, Toro100 up to 97%, and Toro250 up to 99%. Compare ToroChallenge® plans.

Can I use algo orders or automated trading to trade MRNA?

The FREE $100K ToroChallenge® does not permit bots, API trading, or automated/algo trading strategies. Algo or API availability on other ToroChallenge® programs depends on the specific plan, platform and applicable rules.

Ready to trade Moderna stock with trader2B® capital?

Start the FREE $100K ToroChallenge® and trade eligible U.S. stocks including MRNA.

Start FREE $100K Challenge →

100% FREE · No credit card · Day trading

Trade Moderna (MRNA) with a $100K Funded Account

Moderna Financial Highlights

Latest Moderna (MRNA) Stock News

About Moderna (MRNA) Stock

Trade U.S. Stocks with trader2B

Moderna Inc. Stock Insights

Related Stocks

Frequently Asked Questions About MRNA Trading

What should traders know before trading MRNA?

What are the rules for day trading MRNA on a funded account?

How do I qualify to trade Moderna Inc. (MRNA) and what is the profit split?

Can I use algorithms or API bots to trade MRNA?

Why are some U.S. stocks not available to trade on trader2B®?

How and when can I withdraw profits after trading MRNA on a funded account?

What platforms can I use to trade MRNA with trader2B®?

How much buying power do I get to trade MRNA?

Can I get a higher profit split than the FREE $100K Challenge?

Can I use algo orders or automated trading to trade MRNA?

Ready to trade Moderna stock with trader2B® capital?

Why are some U.S. stocks not available to trade on trader2B^®?

What platforms can I use to trade MRNA with trader2B^®?